Literature DB >> 22539784

Kinetics and activation requirements of contact-dependent immune suppression by human regulatory T cells.

Morten Hagness1, Karen Henjum, Johannes Landskron, Kristoffer Watten Brudvik, Bjørn Atle Bjørnbeth, Aksel Foss, Kjetil Taskén, Einar Martin Aandahl.   

Abstract

Naturally occurring regulatory T cells (Tregs) maintain self tolerance by dominant suppression of potentially self-reactive T cells in peripheral tissues. However, the activation requirements, the temporal aspects of the suppressive activity, and mode of action of human Tregs are subjects of controversy. In this study, we show that Tregs display significant variability in the suppressive activity ex vivo as 54% of healthy blood donors examined had fully suppressive Tregs spontaneously, whereas in the remaining donors, anti-CD3/CD2/CD28 stimulation was required for Treg suppressive activity. Furthermore, anti-CD3/CD2/CD28 stimulation for 6 h and subsequent fixation in paraformaldehyde rendered the Tregs fully suppressive in all donors. The fixation-resistant suppressive activity of Tregs operated in a contact-dependent manner that was not dependent on APCs, but could be fully obliterated by trypsin treatment, indicating that a cell surface protein is directly involved. By add-back of active, fixed Tregs at different time points after activation of responding T cells, the responder cells were susceptible to Treg-mediated immune suppression up to 24 h after stimulation. This defines a time window in which effector T cells are susceptible to Treg-mediated immune suppression. Lastly, we examined the effect of a set of signaling inhibitors that perturb effector T cell activation and found that none of the examined inhibitors affected Treg activation, indicating pathway redundancy or that Treg activation proceeds by signaling mechanisms distinct from those of effector T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539784     DOI: 10.4049/jimmunol.1101367

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.

Authors:  Clara S Mundry; Kirsten C Eberle; Pankaj K Singh; Michael A Hollingsworth; Kamiya Mehla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-06-21       Impact factor: 10.680

2.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

3.  The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.

Authors:  Wenpu Zhao; Celine C Berthier; Emily E Lewis; W Joseph McCune; Matthias Kretzler; Mariana J Kaplan
Journal:  Clin Immunol       Date:  2013-07-20       Impact factor: 3.969

4.  Boosting regulatory T cell function by CD4 stimulation enters the clinic.

Authors:  Christian Becker; Tobias Bopp; Helmut Jonuleit
Journal:  Front Immunol       Date:  2012-06-18       Impact factor: 7.561

5.  Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance.

Authors:  Jason Miska; Midhat H Abdulreda; Priyadharshini Devarajan; Jen Bon Lui; Jun Suzuki; Antonello Pileggi; Per-Olof Berggren; Zhibin Chen
Journal:  J Exp Med       Date:  2014-02-24       Impact factor: 14.307

Review 6.  The eye as a novel imaging site in diabetes research.

Authors:  Shao-Nian Yang; Per-Olof Berggren
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

7.  T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression.

Authors:  Alexandra Kegler; Stefanie Koristka; Ralf Bergmann; Nicole Berndt; Claudia Arndt; Anja Feldmann; Anja Hoffmann; Martin Bornhäuser; Marc Schmitz; Michael P Bachmann
Journal:  Oncoimmunology       Date:  2019-06-07       Impact factor: 8.110

Review 8.  Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation.

Authors:  Asiel Arce-Sillas; Diana Denisse Álvarez-Luquín; Beatriz Tamaya-Domínguez; Sandra Gomez-Fuentes; Abel Trejo-García; Marlene Melo-Salas; Graciela Cárdenas; Juan Rodríguez-Ramírez; Laura Adalid-Peralta
Journal:  J Immunol Res       Date:  2016-05-19       Impact factor: 4.818

9.  4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression.

Authors:  Hampartsoum B Barsoumian; Esma S Yolcu; Haval Shirwan
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

Review 10.  Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision.

Authors:  Patrick R Adair; Yong Chan Kim; Ai-Hong Zhang; Jeongheon Yoon; David W Scott
Journal:  Front Immunol       Date:  2017-09-21       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.